RecruitingNot ApplicableNCT07426172

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.


Sponsor

Ricardo Mora

Enrollment

24 participants

Start Date

Jan 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria6

  • Men and women
  • \>18 years of age
  • Women non-pregnant or taking contraceptive medication
  • Physically active according to WHO's guidelines
  • Metabolic syndrome as IDF 2009 criteria (Alberti et al., Circulation)
  • Written and verbal consent to participation

Exclusion Criteria3

  • Chronic illness that prevents them from exercising
  • Affected blood samples at screening, as assessed by the PI
  • Assessed as unsuitable by PI

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERhyperlactacidemia

Raise blood lactate in metabolically healthy individuals to the levels of individuals with metabolic syndrome

OTHERSaline (0.9%, sterile, for infusion)

Saline infusion as a control treatment


Locations(1)

Facultad de Ciencias del Deporte

San Javier, Murcia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07426172


Related Trials